# Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)

> **NCT00239915** · PHASE2 · COMPLETED · sponsor: **Pharmacology Research Institute**

## Conditions studied

- Persistent Developmental Stuttering

## Interventions

- **DRUG:** Pagoclone

## Key facts

- **NCT ID:** NCT00239915
- **Lead sponsor:** Pharmacology Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239915, "Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00239915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*